Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
4.550
-0.050 (-1.09%)
Mar 6, 2026, 4:00 PM EST - Market closed
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $6.38 million as of March 6, 2026. Its market cap has decreased by -62.88% in one year.
Market Cap
6.38M
Enterprise Value
-564.99K
1-Year Change
-62.88%
Ranking
Category
Stock Price
$4.55
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $6.38M, a decrease of -65.50%. That is a compound annual growth rate of -5.95%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuron | 6.88M |
| Moolec Science | 6.79M |
| Creative Medical Technology Holdings | 6.57M |
| Mustang Bio | 6.54M |
| Aptorum Group | 6.51M |
| Theriva Biologics | 6.45M |
| XTL Biopharmaceuticals | 6.43M |
| Processa Pharmaceuticals | 6.41M |